Maki Hirao
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine 3
- Physiology top 10%
-
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- PARP inhibition in cancer therapy 1
- Bone health and treatments 1
-
- Orthopaedic implants and arthroplasty 1
-
- Cancer Mechanisms and Therapy 1
- Co-authors
- Jeff PosakonyJulian A. SimonAntonio BedalovHitoshi ShiozakiMorito MondenMasatoshi InoueManfred JungYuichiro� Doki
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Maki Hirao
16 papers receiving 411 citations
Peers
Comparison fields: 5 of 65
- Geriatrics and Gerontology 123
- Aging 14
- Physiology 32
- Biological Psychiatry 9
- Organic Chemistry 94
Countries citing papers authored by Maki Hirao
This map shows the geographic impact of Maki Hirao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Hirao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Hirao more than expected).
Fields of papers citing papers by Maki Hirao
This network shows the impact of papers produced by Maki Hirao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Hirao. The network helps show where Maki Hirao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maki Hirao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 0 | |
| 11 | [Incidence of Secondary Malignancy of Chronic Myeloid Leukemia during Treatment of Breast Cancer with Hormone Therapy]. | 2021 | 0 |
| 12 | 2021 | 9 | |
| 13 | 2021 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2018 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2004 | 140 | |
| 18 | 2003 | 61 | |
| 19 | 2003 | 110 | |
| 20 | 1998 | 60 |
About Maki Hirao
Maki Hirao is a scholar working on Geriatrics and Gerontology, Hematology and Physiology, having authored 20 papers that have together received 412 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Sirtuins and Resveratrol in Medicine (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), PARP inhibition in cancer therapy (1 paper), Orthopaedic implants and arthroplasty (1 paper), Bone health and treatments (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Geriatrics and Gerontology (123 citations), Aging (14 citations) and Physiology (32 citations). Maki Hirao has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Jeff Posakony, Julian A. Simon, Antonio Bedalov, Hitoshi Shiozaki, Morito Monden, Masatoshi Inoue, Manfred Jung, Yuichiro� Doki, Makoto Osada and Yutaka Hattori. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.